Literature DB >> 23263491

Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia.

Kim De Keersmaecker1, Zeynep Kalender Atak, Ning Li, Carmen Vicente, Stephanie Patchett, Tiziana Girardi, Valentina Gianfelici, Ellen Geerdens, Emmanuelle Clappier, Michaël Porcu, Idoya Lahortiga, Rossella Lucà, Jiekun Yan, Gert Hulselmans, Hilde Vranckx, Roel Vandepoel, Bram Sweron, Kris Jacobs, Nicole Mentens, Iwona Wlodarska, Barbara Cauwelier, Jacqueline Cloos, Jean Soulier, Anne Uyttebroeck, Claudia Bagni, Bassem A Hassan, Peter Vandenberghe, Arlen W Johnson, Stein Aerts, Jan Cools.   

Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is caused by the cooperation of multiple oncogenic lesions. We used exome sequencing on 67 T-ALLs to gain insight into the mutational spectrum in these leukemias. We detected protein-altering mutations in 508 genes, with an average of 8.2 mutations in pediatric and 21.0 mutations in adult T-ALL. Using stringent filtering, we predict seven new oncogenic driver genes in T-ALL. We identify CNOT3 as a tumor suppressor mutated in 7 of 89 (7.9%) adult T-ALLs, and its knockdown causes tumors in a sensitized Drosophila melanogaster model. In addition, we identify mutations affecting the ribosomal proteins RPL5 and RPL10 in 12 of 122 (9.8%) pediatric T-ALLs, with recurrent alterations of Arg98 in RPL10. Yeast and lymphoid cells expressing the RPL10 Arg98Ser mutant showed a ribosome biogenesis defect. Our data provide insights into the mutational landscape of pediatric versus adult T-ALL and identify the ribosome as a potential oncogenic factor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23263491      PMCID: PMC5547913          DOI: 10.1038/ng.2508

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  56 in total

1.  1024C> T (R342X) is a recurrent PHF6 mutation also found in the original Börjeson-Forssman-Lehmann syndrome family.

Authors:  Karen M Lower; Göran Solders; Marie-Louise Bondeson; John Nelson; Arne Brun; Joanna Crawford; Gunilla Malm; Mats Börjeson; Gillian Turner; Michael Partington; Jozef Gécz
Journal:  Eur J Hum Genet       Date:  2004-10       Impact factor: 4.246

2.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

3.  WT1 mutations in T-ALL.

Authors:  Valeria Tosello; Marc R Mansour; Kelly Barnes; Maddalena Paganin; Maria Luisa Sulis; Sarah Jenkinson; Christopher G Allen; Rosemary E Gale; David C Linch; Teresa Palomero; Pedro Real; Vundavalli Murty; Xiaopan Yao; Susan M Richards; Anthony Goldstone; Jacob Rowe; Giuseppe Basso; Peter H Wiernik; Elisabeth Paietta; Rob Pieters; Martin Horstmann; Jules P P Meijerink; Adolfo A Ferrando
Journal:  Blood       Date:  2009-06-03       Impact factor: 22.113

4.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.

Authors:  Xose S Puente; Magda Pinyol; Víctor Quesada; Laura Conde; Gonzalo R Ordóñez; Neus Villamor; Georgia Escaramis; Pedro Jares; Sílvia Beà; Marcos González-Díaz; Laia Bassaganyas; Tycho Baumann; Manel Juan; Mónica López-Guerra; Dolors Colomer; José M C Tubío; Cristina López; Alba Navarro; Cristian Tornador; Marta Aymerich; María Rozman; Jesús M Hernández; Diana A Puente; José M P Freije; Gloria Velasco; Ana Gutiérrez-Fernández; Dolors Costa; Anna Carrió; Sara Guijarro; Anna Enjuanes; Lluís Hernández; Jordi Yagüe; Pilar Nicolás; Carlos M Romeo-Casabona; Heinz Himmelbauer; Ester Castillo; Juliane C Dohm; Silvia de Sanjosé; Miguel A Piris; Enrique de Alava; Jesús San Miguel; Romina Royo; Josep L Gelpí; David Torrents; Modesto Orozco; David G Pisano; Alfonso Valencia; Roderic Guigó; Mónica Bayés; Simon Heath; Marta Gut; Peter Klatt; John Marshall; Keiran Raine; Lucy A Stebbings; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Ivo Gut; Armando López-Guillermo; Xavier Estivill; Emili Montserrat; Carlos López-Otín; Elías Campo
Journal:  Nature       Date:  2011-06-05       Impact factor: 49.962

Review 5.  Does the ribosome translate cancer?

Authors:  Davide Ruggero; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

Review 6.  Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.

Authors:  Clemens Grabher; Harald von Boehmer; A Thomas Look
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

7.  Mutational analysis of the ribosomal protein Rpl10 from yeast.

Authors:  Anne Hofer; Cyril Bussiere; Arlen W Johnson
Journal:  J Biol Chem       Date:  2007-08-30       Impact factor: 5.157

8.  LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).

Authors:  Ryoichi Ono; Tomohiko Taki; Takeshi Taketani; Masafumi Taniwaki; Hajime Kobayashi; Yasuhide Hayashi
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

9.  Alterations of the Notch pathway in lung cancer.

Authors:  Britta Westhoff; Ivan N Colaluca; Giovanni D'Ario; Maddalena Donzelli; Daniela Tosoni; Sara Volorio; Giuseppe Pelosi; Lorenzo Spaggiari; Giovanni Mazzarol; Giuseppe Viale; Salvatore Pece; Pier Paolo Di Fiore
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

10.  The TLX1 oncogene drives aneuploidy in T cell transformation.

Authors:  Kim De Keersmaecker; Pedro J Real; Giusy Della Gatta; Teresa Palomero; Maria Luisa Sulis; Valeria Tosello; Pieter Van Vlierberghe; Kelly Barnes; Mireia Castillo; Xavier Sole; Michael Hadler; Jack Lenz; Peter D Aplan; Michelle Kelliher; Barbara L Kee; Pier Paolo Pandolfi; Dietmar Kappes; Fotini Gounari; Howard Petrie; Joni Van der Meulen; Frank Speleman; Elisabeth Paietta; Janis Racevskis; Peter H Wiernik; Jacob M Rowe; Jean Soulier; David Avran; Hélène Cavé; Nicole Dastugue; Susana Raimondi; Jules P P Meijerink; Carlos Cordon-Cardo; Andrea Califano; Adolfo A Ferrando
Journal:  Nat Med       Date:  2010-10-24       Impact factor: 53.440

View more
  205 in total

1.  Ribosomal 60S-subunit production: the final scene.

Authors:  Célia Plisson-Chastang; Natacha Larburu; Pierre-Emmanuel Gleizes
Journal:  Nat Struct Mol Biol       Date:  2015-11       Impact factor: 15.369

2.  The origin of relapse in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Carmen Vicente; Jan Cools
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

3.  Structural modeling of JAK1 mutations in T-cell acute lymphoblastic leukemia reveals a second contact site between pseudokinase and kinase domains.

Authors:  Kirsten Canté-Barrett; Joost C M Uitdehaag; Jules P P Meijerink
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

Review 4.  Pathways to Specialized Ribosomes: The Brussels Lecture.

Authors:  Jonathan D Dinman
Journal:  J Mol Biol       Date:  2016-01-04       Impact factor: 5.469

5.  Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma.

Authors:  Xinjie Xu; Christian N Paxton; Robert J Hayashi; Kimberly P Dunsmore; Stuart S Winter; Stephen P Hunger; Naomi J Winick; William L Carroll; Mignon L Loh; Meenakshi Devidas; Thomas G Gross; Catherine M Bollard; Sherrie L Perkins; Rodney R Miles
Journal:  Blood Adv       Date:  2021-07-27

Review 6.  The Discovery of Ribosome Heterogeneity and Its Implications for Gene Regulation and Organismal Life.

Authors:  Naomi R Genuth; Maria Barna
Journal:  Mol Cell       Date:  2018-08-02       Impact factor: 17.970

Review 7.  Ribosomopathies: Old Concepts, New Controversies.

Authors:  Katherine I Farley-Barnes; Lisa M Ogawa; Susan J Baserga
Journal:  Trends Genet       Date:  2019-07-31       Impact factor: 11.639

8.  Ribosomal Lesions Promote Oncogenic Mutagenesis.

Authors:  Sergey O Sulima; Kim R Kampen; Stijn Vereecke; Daniele Pepe; Laura Fancello; Jelle Verbeeck; Jonathan D Dinman; Kim De Keersmaecker
Journal:  Cancer Res       Date:  2018-11-27       Impact factor: 12.701

Review 9.  Probing the mechanisms underlying human diseases in making ribosomes.

Authors:  Katherine I Farley; Susan J Baserga
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

10.  Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor Growth.

Authors:  Shauni Lien Geeraerts; Kim Rosalie Kampen; Karin Thevissen; Kim De Keersmaecker; Gianmarco Rinaldi; Purvi Gupta; Mélanie Planque; Nikolaos Louros; Elien Heylen; Kaat De Cremer; Katrijn De Brucker; Stijn Vereecke; Benno Verbelen; Pieter Vermeersch; Joost Schymkowitz; Frederic Rousseau; David Cassiman; Sarah-Maria Fendt; Arnout Voet; Bruno P A Cammue
Journal:  Mol Cancer Ther       Date:  2020-11-17       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.